india pesticides will convene its 41st Annual General Meeting (AGM) on Monday, August 31, 2026, at 12:00 PM (IST) through Video Conferencing or Other Audio Visual Means (VC/OAVM). The meeting aims to seek shareholder approval for the Integrated Annual Report for FY26 and a recommended final dividend of ₹0.75 per equity share. This virtual format ensures broader accessibility for members while complying with regulatory mandates for corporate governance transparency.

The Board of Directors approved the final dividend recommendation during its meeting on May 23, 2026. Shareholders holding equity shares as of the record date, Monday, August 24, 2026, will be eligible to receive the dividend. Payment will be processed within 30 days of the AGM’s conclusion via electronic transfer to registered bank accounts or through warrants for those without updated banking details.

E-Voting and Participation Details

In compliance with Section 108 of the Companies Act, 2013 and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company is facilitating remote e-voting. National Securities Depository Limited (NSDL) has been engaged as the agency to provide the e-voting facility.

Members who have not cast their votes remotely may vote electronically during the AGM via Insta Poll. Once a vote is cast, it cannot be modified. The voting rights are proportional to the paid-up equity share capital held as on the cut-off date.

Regulatory Compliance and Governance

The AGM is being conducted in adherence to various Ministry of Corporate Affairs (MCA) circulars, including General Circular Nos. 20/2020, 02/2022, 10/2022, 09/2023, 09/2024, and 03/2025, which permit holding general meetings through VC/OAVM. Additionally, the process aligns with SEBI Circular No. SEBI/HO/CFD/CFDPoD-2/P/CIR/2024/133 dated October 3, 2024.

Mr. Saket Sharma (FCS: 4229), Partner at M/s GSK & Associates, Company Secretaries, has been appointed as the Scrutinizer to oversee the voting process. The results of the remote e-voting and votes cast during the AGM will be declared within two working days of the meeting’s conclusion. The Scrutinizer’s report and final results will be published on the company’s website and communicated to BSE and NSE.

What the Numbers Show

The recommendation of a ₹0.75 per share final dividend signals management’s confidence in its cash flow generation capabilities for FY26. While the filing does not disclose total revenue or profit figures in this specific notice, the consistent payment of dividends reflects the company’s commitment to returning value to shareholders. Investors should note that dividend income is taxable in the hands of shareholders as per the Income-tax Act, with Tax Deducted at Source (TDS) applied at prescribed rates based on residential status.

India Pesticides Limited reported a 34.8% year-on-year decline in standalone net profit after tax (PAT) to ₹23.07 crore for the quarter ended June 30, 2026, reflecting persistent headwinds in the domestic agrochemical sector. Consolidated PAT fell 34.8% to ₹22.77 crore. The decline was driven by an 8.6% drop in standalone revenue from operations to ₹252.56 crore from ₹275.41 crore in the corresponding period of FY26, attributed to softer domestic demand for its flagship herbicide, Pretilachlor, and increased operational costs including job work processing charges and fuel expenses.

The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 1, 2026. The results were subsequently reviewed by Statutory Auditors and filed with the stock exchanges pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also published extracts of the results in Financial Express (English) and Jansatta (Hindi) on August 2, 2026.

Financial Performance Overview

Consolidated total income from operations stood at ₹251.76 crore, down from ₹275.18 crore in Q1FY26. The consolidated profit before tax was ₹30.85 crore, compared to ₹47.08 crore in the previous year. Earnings per share (basic and diluted) remained consistent at ₹1.98 for both standalone and consolidated figures.

Operational Pressures and Strategic Outlook

The divergence between gross profit stability and bottom-line contraction highlights rising operating leverage pressures. While gross margins have been maintained at healthy levels, downstream manufacturing costs, particularly job work processing charges which jumped to ₹14 crore from ₹8 crore year-on-year, eroded profitability. Export sales showed resilience, increasing marginally to ₹89 crore from ₹87 crore in Q1FY26, supported by stable international demand across 35+ countries, but this growth was insufficient to offset the domestic slowdown.

Dr. Kuruba Adeppa, Whole Time Director, noted that elevated channel inventory and higher fuel costs further strained profitability in the quarter. Despite near-term pressures, management emphasized a focus on operational efficiency and cost management. A key strategic milestone highlighted was the receipt of Technical Equivalence (TEQ) approval from the European Union for a fungicide product, strengthening the company’s position in international markets.

Capacity Expansion and Market Position

India Pesticides Limited continues to leverage its manufacturing capabilities across two primary facilities in Sandila, Hardoi, and Dewa Road, Lucknow, with a combined permitted capacity of 28,200 MT for technicals and 10,000 MT for formulations. A new facility in Hamirpur is under development; two out of ten operating blocks are currently functional for insecticides and herbicides. Two additional blocks are expected to become operational in FY27, contributing to a total permitted capacity expansion of 30,000 MT for technicals and 6,000 MT for formulations.

Revenue concentration remains a focus area, with top 10 customers accounting for 51% of revenue in Q1FY27, up from 40% in FY26. The company is actively reducing dependency on imported intermediates, particularly from China, through in-house R&D and project engineering capabilities, aiming to improve cost efficiencies while sustaining HSE and ESG standards.